Experimental autoimmune encephalomyelitis (EAE) serves as a model for human multiple sclerosis (MS). Both EAE and MS manifest as a consequence of an inflammatory process within the central nervous system (CNS) that is mediated by cells of the immune system. The disease develops when T regulatory cells (Tregs) are no longer able to control activation of myelin-reactive effector T cells. It is thus crucial to understand why Tregs become unable to keep effector T cells in check and how the myelin-reactive lymphocytes evade such control in order to develop approaches that could contain the disease. Recently, we discovered a novel class of thymic stem cell progenitors expressing IL-13 receptor ?1 (IL-13R?1) that contribute to the development and function of both Tregs and effector T cells. The lineage negative (Lin-) IL-13R?1+ stem cells, which arise in the bone marrow (BM), migrate to the thymus and become early thymic progenitors (ETPs). However, these IL-13R?1+ ETPs do not mature into T lymphocytes. Rather, they give rise to CD11b+ myeloid cells that are retained in the thymus and function as antigen-presenting cells (APCs) that contribute to the selection process of both Tregs and effector T cells. The IL-13R?1+ BM stem cells that do not migrate to the thymus also give rise to IL-13R?1+ myeloid cells as well as dendritic cells (DCs) that likely function as peripheral APCs and contribute to the function of Tregs and effector T cells. The long term objective in this proposal is to define the contribution of IL-13R?1+ ETPs to thymic T cell selection and to determine how the IL-13R?1+ BM stem cell-derived peripheral APCs (myeloid and DCs) regulate the function of the ETP-selected Tregs and effector T cells. The major hypothesis in this proposal postulates that IL-13R?1+ETP-derived myeloid cells function as APCs for thymic selection and display discrepancies among effector and regulatory T cells as well as self versus foreign antigens. Ultimately, the thymic outcome dictates T cell output to the periphery and, in coordination with the IL- 13R?1+ peripheral APCs, regulates myelin-reactivity and EAE.
Three aims are proposed to test these hypotheses.
Aim 1 will define the role IL-13R?1+ETPs play in thymic T cell selection, aim 2 will assess the role IL-13R?1+ ETPs play in the development of peripheral T cell responses and EAE, and aim 3 will determine how IL-13R?1+ Lin- BM stem cells regulate T cell responses and EAE. This study is of high impact because it could yield mechanistic insights useful for the generation of therapeutics against EAE and MS.
|Dhakal, Mermagya; Hardaway, John C; Guloglu, Fatma Betul et al. (2014) IL-13R*1 is a surface marker for M2 macrophages influencing their differentiation and function. Eur J Immunol 44:842-55|
|Cascio, Jason A; Khairallah, Marie-Therese; Wan, Xiaoxiao et al. (2014) In trans T cell tolerance exacerbates experimental allergic encephalomyelitis by interfering with protective antibody responses. J Neuroimmunol 266:49-55|
|Cascio, Jason A; Haymaker, Cara L; Divekar, Rohit D et al. (2013) Antigen-specific effector CD4 T lymphocytes school lamina propria dendritic cells to transfer innate tolerance. J Immunol 190:6004-14|
|Wan, Xiaoxiao; Guloglu, F Betul; VanMorlan, Amie M et al. (2012) Mechanisms underlying antigen-specific tolerance of stable and convertible Th17 cells during suppression of autoimmune diabetes. Diabetes 61:2054-65|
|Haymaker, Cara L; Guloglu, F Betul; Cascio, Jason A et al. (2012) Bone marrow-derived IL-13RÃ½Ã½1-positive thymic progenitors are restricted to the myeloid lineage. J Immunol 188:3208-16|
|Divekar, Rohit D; Haymaker, Cara L; Cascio, Jason A et al. (2011) T cell dynamics during induction of tolerance and suppression of experimental allergic encephalomyelitis. J Immunol 187:3979-86|
|Zhang, Jinping; Lee, Sang-Myeong; Shannon, Stephen et al. (2009) The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice. J Clin Invest 119:3048-58|
|Yu, Ping; Haymaker, Cara L; Divekar, Rohit D et al. (2008) Fetal exposure to high-avidity TCR ligand enhances expansion of peripheral T regulatory cells. J Immunol 181:73-80|